Patients with anticonvulsant therapy including off-label use
Conditions
Interventions
Group 1: Patients without additional care by a clinical pharmacist - Control group
Group 2: Patients with additional care by a clinical pharmacist
Based on the identified errors in their drug handling
Sponsors
Universität Leipzig
Eligibility
Sex/Gender
All
Age
No minimum to 21 Years
Inclusion criteria
Inclusion criteria: Patients with at least one anticonvulsant medication prescribed.
Exclusion criteria
Exclusion criteria: Patients that are fostered in a nursing home or served by a nursing service. Patients with an official guardian.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Patients/processes with at least one error in drug handling 3 to 6 weeks after hospital discharge or outpatient visit. Data assessment at home visits by process monitoring of a clinical pharmacist. | — |
Secondary
| Measure | Time frame |
|---|---|
| Reducing the number of medication errors per drug handling process (median) 3 to 6 weeks after hospital discharge or after outpatient visit. | — |
Countries
Germany
Contacts
Public ContactThilo Bertsche
ZAMS - Zentrum für Arzneimittelsicherheit, Universität und Universitätsklinikum Leipzig; Klinische Pharmazie und Pharmazeutische Pharmakologie, Institut für Pharmazie, Universität Leipzig
Outcome results
None listed